PETER CLAUSEN

Insider Reports History

Location
Ijamsville, MD
Signature
/s/ David Jorden, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PETER CLAUSEN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuo Therapeutics, Inc. CSO/COO Common Stock 770,054 $308,021 $0.4000 31 Jul 2025 Direct
Nuo Therapeutics, Inc. CSO/COO Common Stock 3,474 $4,863 $1.40 31 Jul 2025 By spouse
Nuo Therapeutics, Inc. CSO/COO Option to purchase common stock 0 09 Aug 2018 Direct

Insider Reports Filed by PETER CLAUSEN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AURX Nuo Therapeutics, Inc. 31 Jul 2025 2 +$73,541 4 CSO/COO 04 Aug 2025, 09:06
AURX Nuo Therapeutics, Inc. 20 May 2024 1 +$11,250 4 CSO/COO 21 May 2024, 15:13
AURX Nuo Therapeutics, Inc. 19 Dec 2023 1 +$10,000 4 CSO/COO 20 Dec 2023, 14:04
AURX Nuo Therapeutics, Inc. 01 Aug 2023 1 +$50,000 4 CSO/COO 03 Aug 2023, 16:18
AURX Nuo Therapeutics, Inc. 06 Jun 2022 1 $0 4 CSO/COO 15 Jun 2022, 18:18
AURX Nuo Therapeutics, Inc. 29 Apr 2022 1 +$25,000 4 CSO/COO 02 May 2022, 12:23
AURX Nuo Therapeutics, Inc. 04 Mar 2022 1 $0 4 CSO/COO 26 Apr 2022, 21:32
AURX Nuo Therapeutics, Inc. 01 Jan 2022 0 $0 3/A CSO/COO 18 Oct 2022, 13:20